Dublin, Oct. 02, 2023 (GLOBE NEWSWIRE) -- The "Gene Delivery Technologies Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
The global gene delivery technologies market is expected to grow from $3.10 billion in 2022 to $3.57 billion in 2023 at a compound annual growth rate (CAGR) of 15.4%. The gene delivery technologies market is expected to reach $6.11 billion in 2027 at a CAGR of 14.3%.
In today's dynamic world of life sciences, the global gene delivery technologies market stands out as a cornerstone. Revolutionizing the treatment paradigm for genetic diseases and disorders, these technologies deliver foreign genetic materials into cells, marking a transformative era in medicine.
Our comprehensive analysis underscores the rapid evolution of this market, driven by technological advancements and a surging demand for cell and gene therapies. We spotlight the endeavors of leading market players in pioneering state-of-the-art products. Notably, strategic moves like PerkinElmer's acquisition of SIRION Biotech are reshaping the market's trajectory.
With a spike in cell and gene therapies, powered by gene-editing breakthroughs, the market's growth trajectory is on an upward curve. As highlighted in an October 2022 report by Economist Impact, a staggering 2,600 clinical trials for CGTs were active by mid-2021. A testament to the sector's growth, over half of these were initiated post-2015. Projections indicate that the US could see 100 approved CGTs by 2031, averaging 8 or 9 FDA approvals yearly from 2022-2031. Such momentum underscores the burgeoning role of gene delivery technologies.
Gene delivery, essentially the introduction of DNA or RNA into cells, offers hope in treating genetic anomalies, whether mutations or inherited genes. The market is segmented into biological, chemical, and physical modes, with applications spanning gene therapy, cell therapy, vaccines, and research.
Emerging technological advancements underscore the market's dynamism. A case in point: Aera Therapeutics' February 2023 launch of the Aera Platform. This innovative technology targets RNA molecules involved in diseases, paving the way for precise gene editing and heralding the promise of personalized gene treatments.
The strategic acquisition of Germany's SIRION Biotech by US-based PerkinElmer in June 2021 further exemplifies market consolidation. Aimed at bolstering PerkinElmer's gene therapy and viral vector capabilities, this move cements the company's position in gene delivery technologies, ensuring it's poised to cater to the escalating demand for gene therapies.
North America was the largest region in the gene delivery technologies market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period.
The countries covered in the gene delivery technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 175 |
| Forecast Period | 2023 - 2027 |
| Estimated Market Value (USD) in 2023 | $3.57 billion |
| Forecasted Market Value (USD) by 2027 | $6.11 billion |
| Compound Annual Growth Rate | 14.4% |
| Regions Covered | Global |
Major players in the gene delivery technologies market are
- Thermo Fisher Scientific Inc.
- QIAGEN NV
- Horizon Discovery Group Co
- OriGene Technologies Inc.
- Oxford Biomedica Solutions LLC
- SignaGen Laboratories LLC
- Vectalys SAS
- Takara Bio Inc.
- Bio-Rad Laboratories Inc.
- System Biosciences LLC
- Promega Corporation
- Hoffmann-La Roche AG
- Catalent Inc.
- System Biosciences LLC
- Avantor
Key Topics Covered:
1. Executive Summary
2. Gene Delivery Technologies Market Characteristics
3. Gene Delivery Technologies Market Trends And Strategies
4. Gene Delivery Technologies Market - Macro Economic Scenario
4.1. COVID-19 Impact On Gene Delivery Technologies Market
4.2. Ukraine-Russia War Impact On Gene Delivery Technologies Market
4.3. Impact Of High Inflation On Gene Delivery Technologies Market
5. Gene Delivery Technologies Market Size And Growth
5.1. Global Gene Delivery Technologies Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Gene Delivery Technologies Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Gene Delivery Technologies Market Segmentation
6.1. Global Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Biological
- Chemical
- Physical
6.2. Global Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Ex Vivo
- In Vivo
- In Vitro
6.3. Global Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Gene Therapy
- Cell Therapy
- Vaccines
- Research
7. Gene Delivery Technologies Market Regional And Country Analysis
7.1. Global Gene Delivery Technologies Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Gene Delivery Technologies Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
For more information about this report visit https://www.researchandmarkets.com/r/ar4q2c
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
